explore -WSS

explore

author：knowledge 2025-09-30 11:07:05 - browse：99

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Making AI in medicine accessible to smaller, and rural hospitals

WSS

At least 12 people were injured in a blast at a port in northwest Turkey

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

NYC plans to house migrants on an island in the East River

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

hotspot

explore

focus

Apple is now the first public company to be valued at $3 trillion

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Drug repurposing or repositioning? The language matters

Brain worms: The science behind RFK Jr.'s parasitic infection

Activists slam private health insurers over coverage restrictions

Brain worms: The science behind RFK Jr.'s parasitic infection

Guidelines to prevent youth baseball injuries need more muscle

Apple Watch's A

Psychedelics group wrestles with new pharma identity

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

explore

Study: AI not yet building 'n

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Mississippi candidates for statewide offices square off in party primaries

Sanofi strikes deal with Novavax, boosting the vaccine maker

Trump Jan. 6 attorney John Lauro is ex

Illinois to ban advertising for guns allegedly marketed to kids and militants

leisure time

leisure time

hotspot

explore